WELCURE (WELCURE) Fair Value & Analysis
IN · Market cap ₹321M
Fair value as of: Jul 6, 2026
From 6 valuation models · updated today
Price vs Fair Value (12 months)
12‑month range ₹0.2400 – ₹1.24 · fair‑value band ₹0.1300 – ₹0.2400 · the ₹0.2600 price screens above the ₹0.1900 fair value. As of Jul 6, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
WELCURE (WELCURE) currently trades at ₹0.2600, while our model-based Fair Value estimate is ₹0.1900 — implying the stock looks roughly 26.9% overvalued today. We read business quality at 34/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, WELCURE generated revenue of ₹3.7B at a net margin of -1.5%. Revenue grew 167.3% year over year. It earns a return on equity of -5.5%. Fundamentals as of Jul 6, 2026
Our scenario range runs from ₹0.1300 (bear case) to ₹0.2400 (bull case); at ₹0.2600, the current price sits above that range. The share trades about 79% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
WELCURE reported revenue of ₹3.7B in FY2025 versus ₹1.1M in FY2021, a compound +668.1%/yr. Reported net income was −₹54.9M in FY2025.
Is WELCURE fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is WELCURE (WELCURE) undervalued?
What is the fair value of WELCURE?
What is the quality score of WELCURE?
What is the revenue of WELCURE (WELCURE)?
What is the net profit margin of WELCURE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.